Hemant Rathi
We are thrilled to announce that EasySLR has successfully secured pre-seed funding from a group of angel investors. This investment is a testament to the potential of our AI-powered platform and its ability to transform the way systematic literature reviews (SLRs) are conducted in the healthcare and pharmaceutical industries.
As researchers with over a decade of experience in conducting SLRs, we have witnessed firsthand the challenges and inefficiencies that affect the traditional review process. EasySLR aims to address these pain points by leveraging the power of large language models (LLMs) and a user-centric approach to automate crucial aspects of the SLR process, providing an intuitive and seamless experience for researchers. Our focus on delivering a superior product experience sets us apart from other solutions in the market.
This new funding will allow us to expand our technology team, further refining our AI capabilities to better serve our users. We will also invest in customer support to ensure that our users receive the best possible experience while using EasySLR. Moreover, we plan to develop specialized AI agents tailored to specific tasks within health economics and outcomes research (HEOR), such as data extraction, quality assessment, and evidence synthesis.
We invite you to explore our newly launched website at https://www.easyslr.com/, where you can find detailed information about our feature set and get answers to any questions you may have. If you're a researcher looking to streamline your SLR process and harness the power of AI, we encourage you to join our waitlist. Your first project is free (no credit card required), so you can experience the benefits of our platform firsthand.
Join us on this exciting journey as we empower researchers to deliver excellence in their systematic reviews.
Hemant Rathi
CEO, EasySLR